Use of dopamine receptor agonists to reduce dopamine receptor number as treatment for tardive dyskinesia.
D014150:Antipsychotic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004185:Disability Evaluation; D004359:Drug Therapy, Combination; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000627:therapeutic use*; D011954:Receptors, Dopamine / Q000032:analysis / Q000187:drug effects*
D014150:Antipsychotic Agents; D011954:Receptors, Dopamine; D007980:Levodopa